Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
Cell Rep ; 43(4): 114101, 2024 Apr 23.
Article En | MEDLINE | ID: mdl-38613786

Syntaxin-1A (stx1a) repression causes a neurodevelopmental disorder phenotype, low latent inhibition (LI) behavior, by disrupting 5-hydroxytryptaminergic (5-HTergic) systems. Herein, we discovered that lysine acetyltransferase (KAT) 3B increases stx1a neuronal transcription and TTK21, a KAT3 activator, induces stx1a transcription and 5-HT release in vitro. Furthermore, glucose-derived CSP-TTK21 could restore decreased stx1a expression, 5-HTergic systems in the brain, and low LI in stx1a (+/-) mice by crossing the blood-brain barrier, whereas the KAT3 inhibitor suppresses stx1a expression, 5-HTergic systems, and LI behaviors in wild-type mice. Finally, in wild-type and stx1a (-/-) mice treated with IKK inhibitors and CSP-TTK21, respectively, we show that KAT3 activator-induced LI improvement is a direct consequence of KAT3B-stx1a pathway, not a side effect. In conclusion, KAT3B can positively regulate stx1a transcription in neurons, and increasing neuronal stx1a expression and 5-HTergic systems by a KAT3 activator consequently improves the low LI behavior in the stx1a ablation mouse model.


E1A-Associated p300 Protein , Syntaxin 1 , Animals , Mice , Disease Models, Animal , Histone Acetyltransferases/metabolism , Histone Acetyltransferases/genetics , Mice, Inbred C57BL , Mice, Knockout , Neurons/metabolism , Phenotype , Serotonin/metabolism , Syntaxin 1/metabolism , Syntaxin 1/genetics , Lysine Acetyltransferases/metabolism , E1A-Associated p300 Protein/metabolism
2.
Aging Cell ; 21(9): e13675, 2022 09.
Article En | MEDLINE | ID: mdl-35962576

The master epigenetic regulator lysine acetyltransferase (KAT) p300/CBP plays a pivotal role in neuroplasticity and cognitive functions. Recent evidence has shown that in several neurodegenerative diseases, including Alzheimer's disease (AD), the expression level and function of p300/CBP are severely compromised, leading to altered gene expression causing pathological conditions. Here, we show that p300/CBP activation by a small-molecule TTK21, conjugated to carbon nanosphere (CSP) ameliorates Aß-impaired long-term potentiation (LTP) induced by high-frequency stimulation, theta burst stimulation, and synaptic tagging/capture (STC). This functional rescue was correlated with CSP-TTK21-induced changes in transcription and translation. Mechanistically, we observed that the expression of a large number of synaptic plasticity- and memory-related genes was rescued, presumably by the restoration of p300/CBP mediated acetylation. Collectively, these results suggest that small-molecule activators of p300/CBP could be a potential therapeutic molecule for neurodegenerative diseases like AD.


Nanospheres , Acetylation , Acetyltransferases/metabolism , Carbon/metabolism , Glucose/metabolism , Hippocampus/metabolism , Histones/metabolism , Pyramidal Cells/metabolism
3.
Sci Transl Med ; 11(487)2019 04 10.
Article En | MEDLINE | ID: mdl-30971452

After a spinal cord injury, axons fail to regenerate in the adult mammalian central nervous system, leading to permanent deficits in sensory and motor functions. Increasing neuronal activity after an injury using electrical stimulation or rehabilitation can enhance neuronal plasticity and result in some degree of recovery; however, the underlying mechanisms remain poorly understood. We found that placing mice in an enriched environment before an injury enhanced the activity of proprioceptive dorsal root ganglion neurons, leading to a lasting increase in their regenerative potential. This effect was dependent on Creb-binding protein (Cbp)-mediated histone acetylation, which increased the expression of genes associated with the regenerative program. Intraperitoneal delivery of a small-molecule activator of Cbp at clinically relevant times promoted regeneration and sprouting of sensory and motor axons, as well as recovery of sensory and motor functions in both the mouse and rat model of spinal cord injury. Our findings showed that the increased regenerative capacity induced by enhancing neuronal activity is mediated by epigenetic reprogramming in rodent models of spinal cord injury. Understanding the mechanisms underlying activity-dependent neuronal plasticity led to the identification of potential molecular targets for improving recovery after spinal cord injury.


Axons/physiology , CREB-Binding Protein/metabolism , Environment , Histones/metabolism , Nerve Regeneration , Spinal Cord Injuries/metabolism , Spinal Cord Injuries/physiopathology , Acetylation , Animals , Calcium/metabolism , Disease Models, Animal , E1A-Associated p300 Protein/metabolism , Ganglia, Spinal/pathology , Ganglia, Spinal/physiopathology , Mice , Motor Neurons/pathology , Proprioception , Recovery of Function , Sensory Receptor Cells/pathology , Signal Transduction , Spinal Cord Injuries/pathology
...